← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2005Last known activity
Jul 31, 2024
Timeline
1980s
- Jun 1, 1986
I-Shou University— Founded
Drugs by trial phase (39 distinct, 31 trials)
Phase 4 (22 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Atrial Fibrillation
- Carcinoma
- Carcinoma, Hepatocellular
- Cerebral Infarction
- Chronic Pain
- Drug-Related Side Effects and Adverse Reactions
- Esophageal and Gastric Varices
- Fatigue
- Heart Failure
- Heart Failure, Systolic
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- HIV Infections
- Infections
- Ischemia
- Mitral Valve Insufficiency
- Neutropenia
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Pneumonia
- Postoperative Pain
- Recurrence
- Stroke
- Varicose Veins
Recent trials (42)
- NCT06198699CollaboratorN/AJul 31, 2024
- NCT06447441CollaboratorN/AJul 1, 2024
- NCT06420388Lead sponsorN/AMay 1, 2023
- NCT06420388OfficialN/AMay 1, 2023
- NCT05793268Sponsor investigatorN/ADec 20, 2022
- NCT05793268Lead sponsorN/ADec 20, 2022
- NCT05793268Reponsible party - principal investigatorN/ADec 20, 2022
- NCT05187520Lead sponsorPhase 2Sep 1, 2022
- NCT05187520Reponsible party - principal investigatorPhase 2Sep 1, 2022
- NCT04808544Lead sponsorPhase 2/Phase 3Aug 30, 2021
- NCT04651361Overall official - principal investigatorPhase 2/Phase 3Mar 1, 2021
- NCT04651361Reponsible party - principal investigatorPhase 2/Phase 3Mar 1, 2021
- NCT04651361Lead sponsorPhase 2/Phase 3Mar 1, 2021
- NCT04496882CollaboratorPhase 4Jul 25, 2020
- NCT04056806Lead sponsorPhase 4Aug 31, 2019
Details
- Founded
- Dashu District, TW Jun 1, 1986
- Last known activity
- Jul 31, 2024